- Home
- TXG vs KYN Comparison
TXG vs KYN Comparison
Compare TXG & KYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- KYN
- Stock Information
- Founded
- TXG 2012
- KYN 2004
- Country
- TXG United States
- KYN United States
- Employees
- TXG N/A
- KYN N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- KYN Finance/Investors Services
- Sector
- TXG Industrials
- KYN Finance
- Exchange
- TXG Nasdaq
- KYN Nasdaq
- Market Cap
- TXG 1.7B
- KYN 2.1B
- IPO Year
- TXG 2019
- KYN N/A
- Fundamental
- Price
- TXG $13.36
- KYN $12.16
- Analyst Decision
- TXG Buy
- KYN
- Analyst Count
- TXG 11
- KYN 0
- Target Price
- TXG $13.41
- KYN N/A
- AVG Volume (30 Days)
- TXG 3.6M
- KYN 561.5K
- Earning Date
- TXG 08-07-2025
- KYN 01-01-0001
- Dividend Yield
- TXG N/A
- KYN 8.99%
- EPS Growth
- TXG N/A
- KYN N/A
- EPS
- TXG N/A
- KYN 0.71
- Revenue
- TXG $644,466,000.00
- KYN N/A
- Revenue This Year
- TXG N/A
- KYN N/A
- Revenue Next Year
- TXG $5.60
- KYN N/A
- P/E Ratio
- TXG N/A
- KYN $13.79
- Revenue Growth
- TXG 2.02
- KYN N/A
- 52 Week Low
- TXG $6.78
- KYN $7.84
- 52 Week High
- TXG $24.76
- KYN $9.88
- Technical
- Relative Strength Index (RSI)
- TXG 55.08
- KYN 41.68
- Support Level
- TXG $12.85
- KYN $12.14
- Resistance Level
- TXG $14.22
- KYN $12.42
- Average True Range (ATR)
- TXG 0.94
- KYN 0.19
- MACD
- TXG -0.09
- KYN -0.02
- Stochastic Oscillator
- TXG 52.02
- KYN 7.84
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About KYN Kayne Anderson Energy Infrastructure Fund Inc.
Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.